BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Balance Sheet
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-20 Cr | ₹-15 Cr | ₹-14 Cr | ₹-8.35 Cr | ₹-4.20 Cr |
What is the latest Total Non-Current Liabilities ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹-20 Cr |
Mar2022 | ₹-15 Cr |
Mar2021 | ₹-14 Cr |
Mar2020 | ₹-8.35 Cr |
Mar2019 | ₹-4.20 Cr |
How is Total Non-Current Liabilities of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-20 Cr | Negative | |
Mar2022 | ₹-15 Cr | Negative | |
Mar2021 | ₹-14 Cr | Negative | |
Mar2020 | ₹-8.35 Cr | Negative | |
Mar2019 | ₹-4.20 Cr | - |
Compare Total Non-Current Liabilities of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹99.6 Cr | -1.9% | -11.6% | -6.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -1.9% |
-11.6% |
-6.2% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses